179 related articles for article (PubMed ID: 16342410)
1. Downregulation of CK2 induces apoptosis in cancer cells--a potential approach to cancer therapy.
Wang G; Unger G; Ahmad KA; Slaton JW; Ahmed K
Mol Cell Biochem; 2005 Jun; 274(1-2):77-84. PubMed ID: 16342410
[TBL] [Abstract][Full Text] [Related]
2. Induction of apoptosis by antisense CK2 in human prostate cancer xenograft model.
Slaton JW; Unger GM; Sloper DT; Davis AT; Ahmed K
Mol Cancer Res; 2004 Dec; 2(12):712-21. PubMed ID: 15634760
[TBL] [Abstract][Full Text] [Related]
3. Targeting CK2 for cancer therapy.
Ahmad KA; Wang G; Slaton J; Unger G; Ahmed K
Anticancer Drugs; 2005 Nov; 16(10):1037-43. PubMed ID: 16222144
[TBL] [Abstract][Full Text] [Related]
4. Systemic administration of antisense oligonucleotides simultaneously targeting CK2α and α' subunits reduces orthotopic xenograft prostate tumors in mice.
Trembley JH; Unger GM; Tobolt DK; Korman VL; Wang G; Ahmad KA; Slaton JW; Kren BT; Ahmed K
Mol Cell Biochem; 2011 Oct; 356(1-2):21-35. PubMed ID: 21761204
[TBL] [Abstract][Full Text] [Related]
5. CK2 modulation of NF-kappaB, TP53, and the malignant phenotype in head and neck cancer by anti-CK2 oligonucleotides in vitro or in vivo via sub-50-nm nanocapsules.
Brown MS; Diallo OT; Hu M; Ehsanian R; Yang X; Arun P; Lu H; Korman V; Unger G; Ahmed K; Van Waes C; Chen Z
Clin Cancer Res; 2010 Apr; 16(8):2295-307. PubMed ID: 20371694
[TBL] [Abstract][Full Text] [Related]
6. Intracellular hydrogen peroxide production is an upstream event in apoptosis induced by down-regulation of casein kinase 2 in prostate cancer cells.
Ahmad KA; Wang G; Ahmed K
Mol Cancer Res; 2006 May; 4(5):331-8. PubMed ID: 16687488
[TBL] [Abstract][Full Text] [Related]
7. Preclinical evaluation of cyclin dependent kinase 11 and casein kinase 2 survival kinases as RNA interference targets for triple negative breast cancer therapy.
Kren BT; Unger GM; Abedin MJ; Vogel RI; Henzler CM; Ahmed K; Trembley JH
Breast Cancer Res; 2015; 17():19. PubMed ID: 25837326
[TBL] [Abstract][Full Text] [Related]
8. Influence of casein kinase II in tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in human rhabdomyosarcoma cells.
Izeradjene K; Douglas L; Delaney A; Houghton JA
Clin Cancer Res; 2004 Oct; 10(19):6650-60. PubMed ID: 15475455
[TBL] [Abstract][Full Text] [Related]
9. Mechanism and efficacy of sub-50-nm tenfibgen nanocapsules for cancer cell-directed delivery of anti-CK2 RNAi to primary and metastatic squamous cell carcinoma.
Unger GM; Kren BT; Korman VL; Kimbrough TG; Vogel RI; Ondrey FG; Trembley JH; Ahmed K
Mol Cancer Ther; 2014 Aug; 13(8):2018-29. PubMed ID: 24867250
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of protein kinase CK2 as a therapeutic target for squamous cell carcinoma of cats.
Cannon CM; Trembley JH; Kren BT; Unger GM; O'Sullivan MG; Cornax I; Modiano JF; Ahmed K
Am J Vet Res; 2017 Aug; 78(8):946-953. PubMed ID: 28738012
[TBL] [Abstract][Full Text] [Related]
11. Response of cancer cells to molecular interruption of the CK2 signal.
Wang H; Davis A; Yu S; Ahmed K
Mol Cell Biochem; 2001 Nov; 227(1-2):167-74. PubMed ID: 11827168
[TBL] [Abstract][Full Text] [Related]
12. Simultaneous blockade of interacting CK2 and EGFR pathways by tumor-targeting nanobioconjugates increases therapeutic efficacy against glioblastoma multiforme.
Chou ST; Patil R; Galstyan A; Gangalum PR; Cavenee WK; Furnari FB; Ljubimov VA; Chesnokova A; Kramerov AA; Ding H; Falahatian V; Mashouf L; Fox I; Black KL; Holler E; Ljubimov AV; Ljubimova JY
J Control Release; 2016 Dec; 244(Pt A):14-23. PubMed ID: 27825958
[TBL] [Abstract][Full Text] [Related]
13. Role of protein kinase CK2 in the regulation of tumor necrosis factor-related apoptosis inducing ligand-induced apoptosis in prostate cancer cells.
Wang G; Ahmad KA; Ahmed K
Cancer Res; 2006 Feb; 66(4):2242-9. PubMed ID: 16489027
[TBL] [Abstract][Full Text] [Related]
14. Toward selective CK2alpha and CK2alpha' inhibitors: Development of a novel whole-cell kinase assay by Autodisplay of catalytic CK2alpha'.
Bollacke A; Nienberg C; Borgne ML; Jose J
J Pharm Biomed Anal; 2016 Mar; 121():253-260. PubMed ID: 26786382
[TBL] [Abstract][Full Text] [Related]
15. Nanoencapsulated anti-CK2 small molecule drug or siRNA specifically targets malignant cancer but not benign cells.
Trembley JH; Unger GM; Korman VL; Tobolt DK; Kazimierczuk Z; Pinna LA; Kren BT; Ahmed K
Cancer Lett; 2012 Feb; 315(1):48-58. PubMed ID: 22050909
[TBL] [Abstract][Full Text] [Related]
16. [Inhibitory effects of siRNA expression plasmid specific to protein kinase CK2alpha on human laryngeal carcinoma xenograft in nude mice].
Wang J; Gong S; Liu Y
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2009 Mar; 23(6):267-70. PubMed ID: 19621601
[TBL] [Abstract][Full Text] [Related]
17. CK2 targeted RNAi therapeutic delivered via malignant cell-directed tenfibgen nanocapsule: dose and molecular mechanisms of response in xenograft prostate tumors.
Ahmed K; Kren BT; Abedin MJ; Vogel RI; Shaughnessy DP; Nacusi L; Korman VL; Li Y; Dehm SM; Zimmerman CL; Niehans GA; Unger GM; Trembley JH
Oncotarget; 2016 Sep; 7(38):61789-61805. PubMed ID: 27557516
[TBL] [Abstract][Full Text] [Related]
18. NKX3.1 is regulated by protein kinase CK2 in prostate tumor cells.
Li X; Guan B; Maghami S; Bieberich CJ
Mol Cell Biol; 2006 Apr; 26(8):3008-17. PubMed ID: 16581776
[TBL] [Abstract][Full Text] [Related]
19. Association of protein kinase CK2 inhibition with cellular radiosensitivity of non-small cell lung cancer.
Li Q; Li K; Yang T; Zhang S; Zhou Y; Li Z; Xiong J; Zhou F; Zhou X; Liu L; Meng R; Wu G
Sci Rep; 2017 Nov; 7(1):16134. PubMed ID: 29170453
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of casein kinase 2 prevents growth of human osteosarcoma.
Takahashi K; Setoguchi T; Tsuru A; Saitoh Y; Nagano S; Ishidou Y; Maeda S; Furukawa T; Komiya S
Oncol Rep; 2017 Feb; 37(2):1141-1147. PubMed ID: 27959425
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]